Arista 7130 Series Leads the Way to 25G Ultra-Low Latency Networking
Driving customer value through innovation SANTA CLARA, Calif.–(BUSINESS WIRE)–Arista Networks (NYSE:ANET) today announced the next…
Month: October 2023
Acxiom Recognized as A Leader in Snowflake’s Modern Marketing Data Stack Report
Acxiom enables joint customers to build leading solutions on Snowflake’s Data Cloud that unlocks valuable…
C3 AI and Shell Expand Collaboration for Asset Monitoring and Predictive Maintenance
C3 AI Reliability to include the AI models and specific features developed by Shell Global…
CentralSquare Partners with RapidSOS to Enhance School Safety by Providing Immediate Emergency Detection and Situational Awareness for Faster Response
RapidSOS will integrate seamlessly into CentralSquare’s Computer Aided Dispatch (CAD) to introduce multimedia services, including…
Palisade Bio to Participate at the Virtual Investor Ask the CEO Conference
Live moderated webcast with J.D. Finley, Chief Executive Officer of Palisade Bio on Wednesday, October…
Palisade Bio to Participate at the Virtual Investor Ask the CEO Conference
Live moderated webcast with J.D. Finley, Chief Executive Officer of Palisade Bio on Wednesday, October…
GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference
– Live moderated webcast with Marc Hertz, Chief Executive Officer of GRI Bio on Tuesday,…
GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference
– Live moderated webcast with Marc Hertz, Chief Executive Officer of GRI Bio on Tuesday,…
Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting
Studies address cost-effectiveness and budget impact of INPEFA, an inhibitor of SGLT2 and SGLT1 INPEFA recently…
Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting
Studies address cost-effectiveness and budget impact of INPEFA, an inhibitor of SGLT2 and SGLT1 INPEFA recently…
Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina
-On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025…
Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina
-On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025…
NurExone Secures Eureka Grant for Collaborative Partnership to Expand to Chronic Spinal Cord Injury Therapy
TORONTO and HAIFA, Israel, Oct. 11, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX)…
NurExone Secures Eureka Grant for Collaborative Partnership to Expand to Chronic Spinal Cord Injury Therapy
TORONTO and HAIFA, Israel, Oct. 11, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX)…
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed…
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed…
SELLAS Announces First Patient Dosed in Phase Ib/II Trial of SLS009 (GFH009) in Relapsed/Refractory Peripheral T-cell Lymphomas
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
SELLAS Announces First Patient Dosed in Phase Ib/II Trial of SLS009 (GFH009) in Relapsed/Refractory Peripheral T-cell Lymphomas
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…